Canaccord Genuity Maintains a 'Hold' on Vertex (VRTX); Raising Numbers on Kalydeco Approval and Premium Pricing
Tweet
Share
E-mailGet Alerts VRTX Hot Sheet
Price: $505.75 -2.07%
Rating Summary:
38 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
38 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Canaccord Genuity maintains a 'Hold' on Vertex (NASDAQ: VRTX) price
target raised by $1 to $34.
Analyst, George Farmer, said, "We increase our 2012 revenue/EPS estimates to $2.98B /$5.73 (from $2.84B/$5.26) on higher Kalydeco sales estimates. Our $34 target is based on a DCF. Per sum-of-parts, we assign $18 and $11 value to Incivek and Kalydeco, respectively. Risks include clinical trial failures and changes in competitive landscapes."
For an analyst ratings summary and ratings history on Vertex click here. For more ratings news on Vertex click here.
Shares of Vertex closed at $36.95 yesterday.
target raised by $1 to $34.
Analyst, George Farmer, said, "We increase our 2012 revenue/EPS estimates to $2.98B /$5.73 (from $2.84B/$5.26) on higher Kalydeco sales estimates. Our $34 target is based on a DCF. Per sum-of-parts, we assign $18 and $11 value to Incivek and Kalydeco, respectively. Risks include clinical trial failures and changes in competitive landscapes."
For an analyst ratings summary and ratings history on Vertex click here. For more ratings news on Vertex click here.
Shares of Vertex closed at $36.95 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RBC Capital on Vertex (VRTX): 'SION Overhang Cleared; We Would Remain Buyers'
- Jefferies on Five Below (FIVE): 'Our latest channel checks reinforce our view that FIVE's momentum extends well beyond viral Squish trends'
- Freedom Broker Upgrades Serve Robotics (SERV) to Buy
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
